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Özet
Amaç
TS-131, mevcut ticari oksimlere potansiyel bir alternatif olarak geliştirilmiş 
bir monopiridinyum aldoksim tipi kolinesteraz reaktivatörüdür. Rat plazma 
örneklerinde TS-131’in konsantrasyonlarının ölçümü için; sensitif, basit ve 
güvenilir  bir  yüksek  basınçlı  sıvı  kromatografisi  (HPLC)  yöntemi  kurmayı 
amaçladık. 
Gereç ve Yöntemler
TS-131, erkek Sprague Dawley ratlara intramusküler olarak verildi. 30 dakika 
sonra kan örnekleri intrakardiyak olarak alındı. TS-131’in HPLC ile ayırımı 
için, octadecyl silica yapısında analitik kolon ve %92 0.1 M amonyum asetat 
ve %8 metanol içeren mobil faz kullanıldı. Tüm analizler 40 0C’ye ayarlanmış 
kolon fırını içerisinde yapıldı. Analizler, diyot array dedektör ile 242 nm dalga 
boyunda yapıldı. 
Bulgular
3200  µmol/L’lık  stok  standarttan  seri  dilüsyonlarla  elde  edilen  standart-
larla (0.78–3200 µmol/L) hesaplanan kalibrasyon eğrisi lineerdi. Bu HPLC 
yöntemi ile dedekte edilebilen TS-131 aralığı 0.78–3200 µmol/L arasında 
idi. Yöntemin kantitasyon limiti (LOQ)’u 0.39 µmol/L’ydi. HPLC ölçümlerinin 
gün-içi ve günler-arası tekrarlanabilirlilikleri sırasıyla %1.94 ve %1.22 idi. 
Standartın numunelere eklenmesinden (spiking) sonra, ortalama spike geri 
eldeleri %99.2 ile %100.4 arasındaydı. Ortalama geri elde ise %99.8 olarak 
bulundu.
Sonuç
TS-131 ölçümü için; sensitif, basit ve güvenilir bir HPLC yöntemi kuruldu. 
Mevcut diyod array dedektörlü HPLC yöntemi, aynı zamanda çeşitli pirid-
inyum oksimlerin konsantrasyonlarını belirlemek için de kullanılabilir. 
Anahtar Kelimeler
TS-131, Oksim, Kolinesteraz Reaktivatörü, HPLC, Rat.
Abstract
Aim
TS-131  is  a  monopyridinium  aldoxime-type  cholinesterase  reactivator 
developed as a potential alternative to commercially available oximes.  A 
sensitive, simple and reliable high performance liquid chromatography (HPLC) 
method with diode array detector was developed for the measurement of TS-
131 concentrations in rat plasma samples. 
Material and Methods
Male Spraque Dawley rats were treated intramuscularly with TS-131 and the 
samples were collected 30 min. later. Separation was carried out by HPLC 
using octadecyl silica stationary phase and a mobile phase consisting of 92% 
0.1 M ammonium acetate and 8% methanol. Measurements were carried out 
at 40 0C. Quantitative absorbance was monitored at 242 nm. 
Results
The calibration curve was linear through the range of 0.78–3200 µmol/L, 
which is well beyond the detected plasma level range of TS-131. Limit of 
quantitation was 0.39 µmol/L. Intra-day and inter-day precisions of the HPLC 
determinations gave standard deviations as 1.94 and 1.22%, respectively. 
After spiking, average spike recoveries ranged from 99.2% to 100.4% and, 
overall mean recovery of 99.8% was found. 
Conclusion
A  sensitive,  simple  and  reliable  HPLC  method  was  established  for  the 
measurement of TS-131. The presented HPLC method with diyote arrray 
detector  can  also  be  used  to  determine  the  concentrations  of  several 
pyridinium oximes.   
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Introduction
Organophosphates and organophosphonates (organophosphorus com-
pounds, OPs) are serine esterase and protease inhibitors. OPs are widely 
used in all over the world in agriculture as pesticides, insecticides and 
acaricides, in industry and technology as softening agents and additives 
to lubricants [1-3]. They cause an irreversible inhibition of cholinest-
erases (butyrylcholine esterase: EC 3.1.1.8 and acethylcholine esterase: 
EC 3.1.1.7) via a covalent reaction with the serine in the active center 
of the enzymes [1,2}. Some OPs as tabun, sarin, cyclosarin, soman, 
VR and VX are highly toxic “nerve gas” warfare agents. Some of the 
warfare agents have been also misused by terrorist groups. The clinical 
effects of OPs are well known and have been extensively studied and 
described [3-5].  
The reactivators of acethylcholine esterase (AChE) are an essential 
part of antidote treatment during OPs intoxication, together with at-
ropine and diazepam [6]. The reactivator carries a nucleophilic oxime 
group  (an  oximate  anion  in  the  dissociated  form)  which  is  able  to 
cleave the OPs moiety from AChE’s active site and restore the en-
zyme’s  vital  function  [7].  Pralidoxime  (1,2-hydroxyiminomethyl-
1-methylpyridinium  chloride)  and  obidoxime  (3,  Toxogonin,  1,3-
bis(4-hydroxyiminomethylpyridinium)-2-oxapropane  dichloride)  are 
commercially available AChE reactivators. On the other hand, Atropine 
is a necessary antidote component to diminish the cholinergic conse-
quences of OPs intoxication, where diazepam is used for its anticon-
vulsive activity [6,7]. 
However, the commercially available reactivators cannot be used to 
treat the full spectrum of OPs. In particular, few of the compounds are 
effective against tabun and pesticide intoxication [8]. Novel reactiva-
tors are being developed worldwide to cover these deficiencies [9-15]. 
The available oximes have been quantitatively determined using high 
performance liquid chromatography (HPLC). Using this technique, it 
was possible to monitor the blood concentration and urinary elimina-
tion of pralidoxime [16-22]. Urinary elimination of obidoxime was fol-
lowed by reversed-phase chromatography. Detection of obidoxime and 
of the structurally similar other oximes was carried out at 258 nm [20] 
and 304 nm [22]. 
A new AChE reactivator was developed by the authors as a potential 
alternative  to  the  commercially  available  substances.  Its  chemical 
structure was derived from 
the  structures  of  existing 
esterase  reactivators,  es-
pecially  pralidoxime.  The 
newly developed oxime is 
monopyridinium aldoxime. 
It is the so-called TS-131. 
Chemically, it is 3-carboxy-
aldehydepyridinium oxime, 
C6H6N2O, with a molecu-
lar  weight  of  122.134  g/
mol. Its chemical structure 
is given in Figure 1, and its 
1H NMR spectra is shown 
in Figure 2. TS-131 has a maximum absorbance at 242 nm.
The main aims of this study were the determination of TS-131 in rat 
plasma samples and to establish a simple and reliable method. 
Material and Methods
Animals
In the study, 20 adult male Spraque Dawley rats (250 to 300 gr) were 
used. Rats were caged in a controlled environment at 22°C with 12-
hour light/dark cycles. Standard rat feed and reverse-osmosis–purified 
water were provided ad libitum. All rats were allowed to have 1 week 
of acclimation to this environment before the experiment. The rats were 
divided into groups of ten animals. The present study was performed in 
the Research Center of the Gulhane Military Medical Academy with 
the approval of the Gulhane Military Medical Academy Animal Ethics 
Committee, Turkey. 
Chemicals
TS-131 (3-carboxyaldehydepyridinium, with the molecular formula of 
C6H6N2O, and the molecular weight of 122.134) was synthesized in 
the laboratory (Department of Chemistry, Middle East Technical Uni-
versity, Ankara, Turkey). Other chemicals were purchased from com-
mercial sources in the best available quality: methanol, HPLC grade 
(Merck,  Darmstadt,  Germany);  ammonium  acetate,  trichloroacetic 
acid, (Sigma-Aldrich Chemie GmbH, Steinheim, Germany). The wa-
ter was double distilled and deionized and of HPLC grade (Millipore, 
Molsheim, France).
HPLC System
The liquid chromatography system consisted of an Agilent 1100 Au-
tosampler, a HP 1050 HPLC Quaternary Pump, and a HP 1050 Diode 
Şekil 3. Calibration curve for TS-131 measurement when TS-131 solution was prepared with HPLC 
grade water. Each point represents average of three measurements. The linearity was evaluated by 
regression analysis performed by the least-squares method.
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Figure 1. The chemical structure of TS-131 
(3-carboxyaldehydepyridinium)
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Figure 2. The 1H NMR spectra of TS-131.
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Figure 4. Plasma concentration of TS-131 following intramuscularly (i.m.) administration as a single dose 
(300 µmol/kg), 13.20 µmol/L TS-131 at 18.29 min. The peaks not marked are unknown oxidable endog-
enous compounds.Kromatografi / Chromatography
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Array Detector (DAD), HP 1050 solvent/Degassing Module, HP Ther-
mostatted column Compartment all from Agilent Technologies (Wald-
bronn,  Germany). The  3D  ChemStations  Software  of  1100  System 
Access served for evaluation of chromatograms. A Waters Spherisorb 
ODS2 separation column (25 cm × 4.6 mm i.d., particle size: 5 µm) of 
Hichrom (Berkshire, England), containing octadecyl silica as station-
ary phase was used. The mobile phase consisted of 8% methanol and 
92% 0.1 M ammonium acetate. The mobile phase flow rate was 1 mL/
min with isocratic mode. The chromatograms were obtained at 40 0C. 
The size of sample of injection was 50 µL. Ultraviolet absorbance was 
detected at 242 nm.
Animal treatment
300 µmol/kg of TS-131 was intramuscularly (i.m.) injected to male 
Spraque Dawley rats. The rats were sacrificed after 30 min. following 
i.m. administration. In addition, a control group which did not receive 
any treatment was also used. The blood was collected in K3EDTA 
coated tubes (Becton, Dickinson, NJ, USA), gently mixed and centri-
fuged at 3500 rpm for 10 min at 4 0C to obtain the plasma. The plasma 
samples were stored at −80 0C until HPLC analysis.
Plasma pretreatment
Plasma sample aliquots (0.5 mL) were mixed with 0.5 mL of 20% 
trichloroacetic  acid  to  precipitate  the  proteins,  and  centrifuged  at 
13.000 g for 10 min at 4 0C. The supernatant was then injected into the 
HPLC system. 
Calibration
Calibration curve was established. Calibration curve was determined 
using 14 dilutions from a 3200 µmol/L TS-131 stock solution prepared 
with HPLC grade water in the range of 0.78–3200 µmol/L, in triplicate. 
The linearity was evaluated by regression analysis performed by the 
least-squares method and gave R2 = 0.9997. During the day, the TS-
131 solution was stabile (100±2% SD). Endogenous compounds in the 
biological samples separated well from TS-131 that migrated with a 
retention time of 18.29 min. 
Results
We described a high performance liquid chromatographic method with 
diode array detector for measurement of TS-131 in rat plasma samples. 
As shown in Figure 3, the calibration curve for TS-131 dissolved in 
HPLC grade water was linear in the range of 0.78–3200 µmol/L, and 
the limit of quantitation was 0.39 µmol/L. When plasma concentrations 
of TS-131 in rats were studied following intramuscular administration 
of this compound, a HPLC with DAD method was used with isocratic 
mode (flow rate: 1 mL/min) and UV detection at 242 nm.
The calibration curve was determined using 14 calibrators obtained 
from a 3200 µmol/L TS-131 stock solution prepared with HPLC grade 
water.  Regression  analysis  performed  by  the  least-squares  method 
yielded the equation y = 9.14311456x−93.813378 and a correlation co-
efficient of R2 = 0.9997. The required sample pretreatment is simple, 
and the measurement is rapid with a retention time of only 18.29 min.
A simple protein precipitation serves the clean-up before the HPLC 
injection. This protein precipitation method is quite well for the de-
termination of TS-131 in the plasma samples. Intra-day and inter-day 
precisions were expressed in standard deviation of the TS-131 HPLC 
determination, and gave 1.94 and 1.22%, respectively. After spiking of 
TS-131 into control rat plasma, average spike recovery ranged from 
99.2% to 100.4% and, overall mean recovery of 99.8% was found. The 
NMR spectrum of TS-131 has verified its chemical structure.
Plasma level of TS-131 was determined in rats. In the plasma samples 
of rats treated i.m. with 300 µmol/kg TS-131, and the 30 min post-
treatment concentration was 13.20 µmol/L value (Figure 4). 
Discussion
In especially animal studies, esterase reactivators as pralidoxime and 
obidoxime are commonly used to protect from mortality against several 
OPs like paraoxon and tabun. In this area, different groups are working 
on newly developed pyridinium oximes. Lorke et al. [23] have shown 
that to protect from death, two new asymmetric bispyridinium oximes 
(K-27 and K-48) are much more efficient than pralidoxime [24] and 
obidoxime [25]. 
Several techniques including high-performance liquid chromatography 
have been reported to be able to measure concentrations of different 
cholinesterase reactivator oximes in plasma. Kalasz et al. have devel-
oped a HPLC-EC assay for measuring K-27 in different biological sam-
ples [26]. On the other hand, a HPLC-UV method was established to 
determine concentrations of K-27 and K-48 in plasma and brain tissue 
samples by Lorke et al. [23]. Guyon et al. [18] determined pralidoxime 
concentrations by HPLC from samples of rat plasma and urine. 
A sensitive, simple and reliable HPLC method was established for the 
measurement of TS-131. The presented HPLC method with DAD can 
also be used to determine the concentrations of several pyridinium oxi-
mes.   
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